The estimated Net Worth of Rong Zhou is at least $9.05 Milión dollars as of 26 August 2024. Mr. Zhou owns over 4,000 units of Amphastar Pharmaceuticals Inc stock worth over $5,516,027 and over the last 9 years he sold AMPH stock worth over $2,394,644. In addition, he makes $1,134,470 as Executive Vice President - Production Center and President of Armstrong Pharmaceuticals a Inc. at Amphastar Pharmaceuticals Inc.
Rong has made over 26 trades of the Amphastar Pharmaceuticals Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 4,000 units of AMPH stock worth $59,800 on 26 August 2024.
The largest trade he's ever made was selling 22,969 units of Amphastar Pharmaceuticals Inc stock on 3 June 2020 worth over $435,952. On average, Rong trades about 3,932 units every 65 days since 2015. As of 26 August 2024 he still owns at least 122,388 units of Amphastar Pharmaceuticals Inc stock.
You can see the complete history of Mr. Zhou stock trades at the bottom of the page.
Rong Zhou serves as Executive Vice President - Production Center and President of Armstrong Pharmaceuticals, Inc. of the Company. He has served in various executive roles since joining us in October 1998, most recently as Executive Vice President of Production Center since June 2015, President of Armstrong Pharmaceuticals, Inc. (a wholly-owned subsidiary of Amphastar) since March 2014 and as our Senior Vice President of Scientific Affairs since August 2012. Mr. Zhou served as Corporate Vice President of Scientific Affairs from October 2001 until his promotion to Senior Vice President. Mr. Zhou received a B.S. in Chemical Engineering from the Fuzhou University and an M.S. from the Youngstown State University.
As the Executive Vice President - Production Center and President of Armstrong Pharmaceuticals a Inc. of Amphastar Pharmaceuticals Inc, the total compensation of Rong Zhou at Amphastar Pharmaceuticals Inc is $1,134,470. There are 5 executives at Amphastar Pharmaceuticals Inc getting paid more, with Jack Zhang having the highest compensation of $5,969,740.
Rong Zhou is 60, he's been the Executive Vice President - Production Center and President of Armstrong Pharmaceuticals a Inc. of Amphastar Pharmaceuticals Inc since 2015. There are 10 older and 5 younger executives at Amphastar Pharmaceuticals Inc. The oldest executive at Amphastar Pharmaceuticals Inc is Richard Koo, 79, who is the Independent Director.
Rong's mailing address filed with the SEC is C/O AMPHASTAR PHARMACEUTICALS, INC., 11570 6TH STREET, RANCHO CUCAMONGA, CA, 91730.
Over the last 10 years, insiders at Amphastar Pharmaceuticals Inc have traded over $72,457,295 worth of Amphastar Pharmaceuticals Inc stock and bought 66,100 units worth $921,987 . The most active insiders traders include Jack Y.Luo Mary Z. Zhang, Richard K Prins a William J Peters. On average, Amphastar Pharmaceuticals Inc executives and independent directors trade stock every 11 days with the average trade being worth of $1,459,051. The most recent stock trade was executed by Floyd F. Petersen on 5 September 2024, trading 3,000 units of AMPH stock currently worth $139,410.
amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int
Amphastar Pharmaceuticals Inc executives and other stock owners filed with the SEC include: